Online Public Relations Thoughts

 Pfizer and BioNTech have won the race to be the first vaccine makers to get emergency approval for a COVID vaccine.  Now comes the hard part -- manufacturing and distributing the doses to millions of people who must receive two shots three weeks apart.  It is time for quiet satisfaction at the two companies but not public crowing.  Both know much could still go wrong in the rollout even though they have planned in depth for it.  The time for a PR glow is still in the future.  Today, manufacturing and logistics teams have buckled down to hard work.  If they are successful in the months to come, Pfizer and BioNTech can proudly and rightly publicize what they have done for humanity.